Diseases of the cardiovascular system are the leading cause of morbidity and mortality in men and women in developed countries, and CVD is becoming more prevalent in developing countries. Atherosclerotic cardiovascular disease (CVD) prevalence in men is greater than in women until menopause, when the prevalence of CVD increases in women until it exceeds that of men. Endothelial function is a barometer of vascular health and a predictor of atherosclerosis that may provide insights into sex differences in CVD, as well as how and why CVD risk drastically changes with menopause. Studies of sex differences in endothelial function are conflicting, with some studies showing earlier decrements in endothelial function in men compared to women, while others showing similar age-related declines between the sexes. Because the increase in CVD risk coincides with menopause, it is generally thought that female hormones, in particular estrogens, are cardioprotective. Further, it is often proposed that androgens are detrimental. In truth, the relationships are more complex. This review will first address female and male sex hormones and their receptors, and how these interact with the cardiovascular system, particularly the endothelium, in healthy young women and men. Second, we will address sex differences in sex steroid receptor-independent mechanisms controlling endothelial function, focusing on the vascular endothelin and the renin-angiotensin systems, in healthy young women and men. Finally, we will discuss sex differences in age-associated endothelial dysfunction, focusing on the role of attenuated circulating sex-hormones in these effects.